Medical Devices Companies in Glasgow: 40+ Active Firms (2026)

Glasgow has 41 actively trading medical device companies, a small local cohort within a sector where product assurance and route-to-market discipline matter as much as manufacturing capacity. Reported employment totals 257 people, which points to a market made up largely of specialist developers, assemblers and suppliers rather than high-headcount plants. None of the companies report turnover above £5M, while 8 have been incorporated since 2022. That combination suggests some recent formation activity, but limited evidence of revenue-scale device manufacturers.

Devices placed on the Great Britain market sit under MHRA oversight, with GOV.UK guidance requiring registration before supply for medical devices, in vitro diagnostics, custom-made devices and systems or procedure packs. The main domestic framework is the Medical Devices Regulations, with conformity assessment, product marking and technical documentation shaping market access. UKCA marking is the Great Britain route, although certain CE-marked devices continue to be accepted under transitional rules. Non-UK manufacturers need a UK responsible person, and Northern Ireland follows separate EU medical-device and in vitro diagnostic rules. The Association of British HealthTech Industries is the relevant trade body for the wider health technology sector.

Commercial development appears likely to remain measured, with the Glasgow cohort weighted towards specialist supply, development and assembly rather than large manufacturing platforms. Firms able to keep regulatory documentation, quality systems and post-market responsibilities in house should be better placed to handle Great Britain access requirements, particularly where overseas manufacturers need local accountability. Early-commercial businesses may still find procurement cycles slow, especially when clinical evidence, product marking and reimbursement-style budget approval have to align. Consolidation pressure tends to favour distributors and procedure-pack specialists, while device developers may stay comparatively small unless they secure clinical validation and repeatable routes into healthcare buyers.